AstraZeneca
A Discovery Scientist at EsoBiotec (part of AstraZeneca) will contribute to advancing lentiviral vector therapeutics for cell and gene therapy in oncology. The role sits within discovery research and supports platform development, cross-functional collaboration, and translation toward clinical applications. This position emphasizes innovation in viral vector technologies and driving scientific impact within a biotech–pharma environment.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Scientist
Asimov
Senior Associate Scientist, AAV Cell Line Development (Contractor)
Asimov
Exec Director, Viral Vector Process Development
Gilead Sciences
Director of Vector Engineering and Manufacturing Quality - Cell Therapy
Marriott International
Senior Scientist – Functional Genomics
Amgen
Senior Research Engineer/Scientist Analysis - Viral Vector
Cepheid